Summary
Machine-generated summaryHUS Group, the joint authority for Helsinki and Uusimaa, together with the wellbeing services counties of Southwest Finland, Pirkanmaa and North Ostrobothnia, purchased the tisagenlecleucel medicinal product Kymriah, containing 1.2x10e6 to 6x10e8 cells in infusion fluid. The product was intended for treating B-cell acute lymphoblastic leukaemia in paediatric patients and young adult patients up to 25 years of age, in line with the recommendation of the Council for Choices in Health Care in Finland (Palko) of 13 March 2019. It covers cases where the disease is treatment resistant, has relapsed two or more times, or has relapsed after a stem cell transplant. The contract was awarded.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago
What this market pays
The buyer has too few awards of its own in this sector, so this is the range of the last 617 awards for Medical equipment & pharmaceuticals in Finland.
- Median award
- €497,716
- Middle half of past awards
- €250,000 to €1.4M
TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileHUS Group, the joint authority for Helsinki and Uusimaa; Varsinais-Suomen hyvinvointialue; Pirkanmaan hyvinvointialue; Pohjois-Pohjanmaan hyvinvointialue
- notices in the register
- 2
- awards
- 2
- awarded in total
- €2.0M
Recent awards
Market context
- open now in Medical equipment & pharmaceuticals
- 8,212
- median open notice
- €308,919
Who wins in this market
Many suppliersFinland · Medical equipment & pharmaceuticals
- different companies won awards here
- 415
- of the awards went to the three most frequent winners
- 8%
- buyers awarded contracts here
- 164
Based on 618 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 3.0
- of those lots received a single tender
- 17%
- of the awards went to companies based in another country
- 9%
- of the tenders came from another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
2
days left
€115,000
est. value
Awarded before
Never miss a tender like this
31 new notices in Medical equipment & pharmaceuticals in Finland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Pharmaceutical products: an email when new tenders arrive under it, no account needed.